• A study of SKB410, enfortumab vedotin, and pembrolizumab combination for patients with locally advanced or metastatic urothelial cancer

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France The Netherlands Spain
  • Study of ublituximab compared to fingolimod for children and teenagers aged 10 to 17 years with relapsing multiple sclerosis

    Recruiting

    4 1 1
    Investigated diseases:
    Investigated drugs:
    Poland Slovakia
  • Study comparing firmonertinib with osimertinib or afatinib for patients with advanced lung cancer with uncommon EGFR mutations

    Recruiting

    3 1 1 1
    Investigated diseases:
    France Greece Italy Spain
  • A Study of IPN01203 for Adults With Advanced or Metastatic Solid Tumors After Immune Checkpoint Inhibitor Treatment

    Recruiting

    2 1 1
    Investigated diseases:
    France Spain
  • A Study of S-606001 Added to Enzyme Replacement Therapy for Patients with Late-Onset Pompe Disease

    Recruiting

    2 1
    Investigated diseases:
    Belgium Denmark France Germany Italy The Netherlands +1
  • A Study of Cemiplimab Given Before Surgery in Patients with Early Stage Merkel Cell Carcinoma of the Skin

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Germany
  • A Study of Ponsegromab Combined with Chemotherapy for Adults with Pancreatic Cancer that has Spread and Caused Weight Loss

    Recruiting

    4 1 1
    Investigated drugs:
    Belgium Bulgaria France Germany Italy Poland +2
  • Testing Aganirsen Eye Drops in Patients with Corneal Blood Vessel Growth from Herpes Eye Disease Before Corneal Transplant Surgery

    Recruiting

    2 1 1
    Investigated drugs:
    Germany
  • A Study of IPN60300 in Adults with Locally Advanced or Metastatic Solid Tumors to Assess Safety, Tolerability and Anti-Cancer Activity

    Recruiting

    2 1 1
    Investigated diseases:
    France Spain
  • A Study Testing the Safety of LTX-002 Sodium Given into the Spinal Canal in Adults with Amyotrophic Lateral Sclerosis

    Recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy The Netherlands Sweden

powered by